Success Metrics

Clinical Success Rate
100.0%

Based on 12 completed trials

Completion Rate
100%(12/12)
Active Trials
0(0%)
Results Posted
17%(2 trials)

Phase Distribution

Ph not_applicable
8
67%
Ph phase_3
1
8%
Ph phase_4
3
25%

Phase Distribution

0

Early Stage

0

Mid Stage

4

Late Stage

Phase Distribution12 total trials
Phase 3Large-scale testing
1(8.3%)
Phase 4Post-market surveillance
3(25.0%)
N/ANon-phased studies
8(66.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

12 of 12 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

12

all time

Status Distribution
Completed(12)

Detailed Status

Completed12

Development Timeline

Analytics

Development Status

Total Trials
12
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 31 (8.3%)
Phase 43 (25.0%)
N/A8 (66.7%)

Trials by Status

completed12100%

Recent Activity

Clinical Trials (12)

Drug Details

Intervention Type
OTHER
Total Trials
12